RxDoctor Payments DataLook up a doctor →

Diana Kerwin

Geriatric Medicine · Dallas, TXNPI 1750335097

Payments from drug & device makers

$12,736,010in general payments, 2019–2025

Across 548 payments — averaging $23,241 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$7.5M
  • Eisai Inc.$1.5M
  • AbbVie$1.4M
  • Genentech, Inc.$918K
  • E.r. Squibb & Sons, L.L.C.$460K
  • Novartis$366K
  • plus $596K from 17 others
$42,218in research payments, 2019–2025

Across 17 payments — averaging $2483.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$38K
  • F. Hoffmann-la Roche AG$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,736,010 in reported general payments places this provider in the 95th percentile of 275 geriatric medicine providers in Texas.

See all geriatric medicine providers in Texas

Other geriatric medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →